Pagina 3 - Small Cap Swedish (OMX) Pharmaceuticals & Biotech Aandelen naar marktkapitalisatie

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED May 27, 2026

Ontdek small cap Swedish Pharmaceuticals & Biotech bedrijven die op de OMX. Deze Pharmaceuticals & Biotech Companies zijn gerangschikt op Market Cap.

92 bedrijven

Bedrijf	Laatste prijs	7D Terugkeer	1 J Rendement	Marktkapitalisatie	Doel analisten	Waardering	Groei	Div Opbrengst
PRO	SEK 10.80	-18.2%	-39.8%	SEK 204.0m	n/a	4.1	n/a	n/a
XINT	SEK 0.25	-3.5%	-36.4%	SEK 215.3m	n/a	94.4	n/a	n/a
ISOFOL	SEK 0.70	-2.0%	-36.9%	SEK 225.3m	SEK 3.60	2.4	62.5%	n/a
XBRANE	SEK 11.00	-5.6%	-59.1%	SEK 226.7m	SEK 15.00	3.0	34.3%	n/a
NICA	SEK 0.71	9.2%	-35.5%	SEK 233.4m	SEK 1.70	9.7	50.7%	n/a
IMMU	SEK 5.61	-2.6%	11.5%	SEK 344.2m	SEK 16.00	0.6	42.1%	n/a
SPRINT	SEK 3.52	2.9%	698.2%	SEK 371.4m	SEK 4.80	4.4	3.6%	n/a
DICOT	SEK 0.21	-9.8%	-58.1%	SEK 418.3m	n/a	7.2	n/a	n/a
ACE	SEK 3.26	12.8%	-24.1%	SEK 435.3m	SEK 5.60	5.2	104.9%	n/a
IVACC	SEK 1.28	6.7%	20.3%	SEK 435.6m	SEK 2.10	22.8	3.8%	n/a
CESSA	DKK 16.25	0.6%	20.7%	DKK 301.9m	n/a	52.8	n/a	n/a
CLBIO	SEK 17.75	1.1%	81.1%	SEK 463.9m	SEK 29.00	43.5	47.3%	n/a
MOB	SEK 10.68	-2.6%	14.5%	SEK 502.0m	SEK 14.00	34.4	100.9%	n/a
CINPHA	SEK 11.96	0.3%	-17.9%	SEK 556.6m	SEK 46.25	8.2	-18.3%	n/a
FLUO	SEK 39.80	-3.2%	-5.0%	SEK 650.7m	SEK 73.88	1891.9	9.8%	n/a
ENZY	SEK 2.84	17.4%	-3.1%	SEK 689.4m	n/a	13.0	n/a	n/a
IBT B	SEK 52.00	-5.3%	-8.3%	SEK 700.5m	n/a	8.5	n/a	n/a
CANTA	SEK 2.92	-16.0%	98.0%	SEK 725.4m	SEK 10.50	4.5	-54.8%	n/a
HAMLET B	SEK 4.20	14.3%	1.4%	SEK 746.3m	n/a	4191.0	n/a	n/a
ORX	SEK 21.70	13.4%	47.4%	SEK 757.8m	SEK 29.00	42.6	16.5%	n/a
ONCO	SEK 2.03	4.1%	14.7%	SEK 803.2m	SEK 2.60	9.7	87.0%	n/a
SYNACT	SEK 15.94	11.0%	5.1%	SEK 892.7m	SEK 34.65	4.6	63.7%	n/a
MVIR	SEK 2.01	0.6%	12.8%	SEK 1.1b	SEK 4.98	119.9	1.6%	n/a
CURAS	DKK 15.65	4.7%	324.1%	DKK 756.7m	n/a	42.2	n/a	n/a

Page 3 of 4